- Home
- SCYX vs GORV Comparison
SCYX vs GORV Comparison
Compare SCYX & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- GORV
- Stock Information
- Founded
- SCYX 1999
- GORV 1976
- Country
- SCYX United States
- GORV United States
- Employees
- SCYX N/A
- GORV N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- GORV Retail-Auto Dealers and Gas Stations
- Sector
- SCYX Health Care
- GORV Consumer Discretionary
- Exchange
- SCYX Nasdaq
- GORV Nasdaq
- Market Cap
- SCYX 28.5M
- GORV 25.3M
- IPO Year
- SCYX 2014
- GORV 2015
- Fundamental
- Price
- SCYX $0.70
- GORV $5.55
- Analyst Decision
- SCYX
- GORV Hold
- Analyst Count
- SCYX 0
- GORV 2
- Target Price
- SCYX N/A
- GORV $60.00
- AVG Volume (30 Days)
- SCYX 182.9K
- GORV 35.5K
- Earning Date
- SCYX 08-07-2025
- GORV 08-15-2025
- Dividend Yield
- SCYX N/A
- GORV N/A
- EPS Growth
- SCYX N/A
- GORV N/A
- EPS
- SCYX N/A
- GORV N/A
- Revenue
- SCYX $2,630,000.00
- GORV $767,257,000.00
- Revenue This Year
- SCYX $410.22
- GORV $15.65
- Revenue Next Year
- SCYX $248.83
- GORV $20.54
- P/E Ratio
- SCYX N/A
- GORV N/A
- Revenue Growth
- SCYX N/A
- GORV N/A
- 52 Week Low
- SCYX $0.66
- GORV $3.95
- 52 Week High
- SCYX $2.21
- GORV $98.40
- Technical
- Relative Strength Index (RSI)
- SCYX 43.16
- GORV 42.24
- Support Level
- SCYX $0.67
- GORV $6.01
- Resistance Level
- SCYX $0.74
- GORV $7.45
- Average True Range (ATR)
- SCYX 0.04
- GORV 0.72
- MACD
- SCYX 0.00
- GORV -0.05
- Stochastic Oscillator
- SCYX 18.79
- GORV 16.36
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.